ABT vs. DVA: Abbott Laboratories vs. DaVita Stock Comparison

November 11, 2026

How do Abbott Laboratories (ABT) and DaVita (DVA) stack up? This page sets them side by side across company profile, performance and risk, profitability, growth, financial strength, dividends, and valuation, with selected fundamentals also measured against each stock's industry-group peers.

Company Profile

Abbott Laboratories (ABT) and DaVita (DVA) both fall under the Health Care Equipment & Services industry group, but ABT is classified in Health Care Equipment & Supplies while DVA is classified in Health Care Providers & Services.

Company profile comparison for Abbott Laboratories (ABT) and DaVita (DVA)
Profile Item	ABT	DVA
Name	Abbott Laboratories	DaVita Inc.
Country/Region	United States	United States
GICS Sector	Health Care	Health Care
GICS Industry Group	Health Care Equipment & Services	Health Care Equipment & Services
GICS Industry	Health Care Equipment & Supplies	Health Care Providers & Services
GICS Sub-Industry	Health Care Equipment	Health Care Services
Market Capitalization	190.39 billion USD	12.04 billion USD
Currency	USD	USD
Exchange	NYSE	NYSE
Listing Date	March 17, 1980	October 31, 1995
Security Type	Common Stock	Common Stock

Price Performance

Cumulative Growth

ABT

DVA

GSPC

Abbott Laboratories (ABT) vs. DaVita (DVA), with S&P 500 (GSPC) for reference: Growth of a $10,000 investment over the past five years. Adjusted for dividends and splits.

Trailing Returns

Loading price history…

Trailing total returns for Abbott Laboratories (ABT) and DaVita (DVA). Returns over one year are annualized.

Calendar-Year Returns

Loading price history…

Calendar-year total returns for Abbott Laboratories (ABT) and DaVita (DVA). Each bar is that year's total return, measured year-end to year-end.

Performance Metrics

Price performance metrics for Abbott Laboratories (ABT) and DaVita (DVA)
Metric	ABT	DVA
Total Return (1Y)	-10.78%	51.64%
Total Return (3Y, Annualized)	7.79%	30.54%
Total Return (5Y, Annualized)	-0.79%	11.92%

Risk Profile

Drawdown History

ABT

DVA

GSPC

Abbott Laboratories (ABT) vs. DaVita (DVA), with S&P 500 (GSPC) for reference: Drawdown from the running peak over the past five years. Each line shows the decline from its prior peak; 0% marks a new high.

Return Distribution

Loading price history…

Distribution of monthly total returns for Abbott Laboratories (ABT) and DaVita (DVA). Each bar is the share of months whose return fell in that 5% bucket.

Risk Metrics

Risk profile metrics for Abbott Laboratories (ABT) and DaVita (DVA)
Metric	ABT	DVA
Volatility (1Y, Annualized)	28.48%	46.86%
Beta (5Y)	0.53	0.85
Max Drawdown (5Y)	-39.64%	-46.98%
Avg. Volume (3M)	8.74M	713.76K

Risk-Adjusted Performance

Risk-Return Positioning

ABT and DVA are plotted by 1-year volatility (risk) and 1-year return. The dashed Capital Allocation Line runs from the risk-free rate through the shared industry median.

Risk-Adjusted Metrics

Risk-adjusted metrics for Abbott Laboratories (ABT) and DaVita (DVA)
Metric	ABT	DVA
Sharpe Ratio (1Y)	-0.53	1.01
Sortino Ratio (1Y)	-0.76	1.78

Profitability

ROE (TTM)

DaVita (DVA) at 96.79% clears its industry range for ROE, a sharper capital-efficiency signal than Abbott Laboratories (ABT) at 9.14%, which is closer to a typical peer reading.

ABT

Health Care Equipment & Services industry group

9.14%

Max: 47.61%
Q3: 14.36%
ABT: 9.14%
Median: 5.45%
Q1: -10.67%
Min: -47.01%

DVA

Health Care Equipment & Services industry group

96.79%

DVA: 96.79%
Max: 47.61%
Q3: 14.36%
Median: 5.45%
Q1: -10.67%
Min: -47.01%

Abbott Laboratories (ABT) vs. DaVita (DVA): A comparison of their ROE against the Health Care Equipment & Services industry group benchmark.

Net Margin (TTM)

Abbott Laboratories (ABT) at 9.75% retains a top-quartile share of revenue as profit, ahead of DaVita (DVA) at 6.49%, which keeps about the industry-typical share.

ABT

Health Care Equipment & Services industry group

9.75%

Max: 29.35%
ABT: 9.75%
Q3: 9.33%
Median: 2.18%
Q1: -6.29%
Min: -28.46%

DVA

Health Care Equipment & Services industry group

6.49%

Max: 29.35%
Q3: 9.33%
DVA: 6.49%
Median: 2.18%
Q1: -6.29%
Min: -28.46%

Abbott Laboratories (ABT) vs. DaVita (DVA): A comparison of their net margin against the Health Care Equipment & Services industry group benchmark.

Operating Margin (TTM)

DaVita (DVA) at 15.46% operates in the top operating margin quartile, ahead of Abbott Laboratories (ABT) at 11.66%, which runs around its industry’s norm.

ABT

Health Care Equipment & Services industry group

11.66%

Max: 35.43%
Q3: 14.14%
ABT: 11.66%
Median: 6.81%
Q1: -0.28%
Min: -16.29%

DVA

Health Care Equipment & Services industry group

15.46%

Max: 35.43%
DVA: 15.46%
Q3: 14.14%
Median: 6.81%
Q1: -0.28%
Min: -16.29%

Abbott Laboratories (ABT) vs. DaVita (DVA): A comparison of their operating margin against the Health Care Equipment & Services industry group benchmark.

Profitability Metrics

Profitability metrics for Abbott Laboratories (ABT) and DaVita (DVA)
Metric	ABT	DVA
ROE (TTM)	9.14%	96.79%
ROA (TTM)	4.90%	7.59%
Net Margin (TTM)	9.75%	6.49%
Operating Margin (TTM)	11.66%	15.46%
Gross Margin (TTM)	57.17%	32.28%

Growth

Revenue Growth

Both Abbott Laboratories (ABT) at 5.67% and DaVita (DVA) at 6.46% land near their industries' usual revenue growth ranges, so top-line momentum looks broadly in line with peers on both sides.

Abbott Laboratories (ABT) vs. DaVita (DVA): A comparison of their Revenue Growth across different time periods.

EPS Growth

DaVita (DVA) at -8.29% is around its peer norm for EPS growth, while Abbott Laboratories (ABT) at -51.31% drops into the bottom quartile, signaling weaker earnings momentum.

Abbott Laboratories (ABT) vs. DaVita (DVA): A comparison of their EPS Growth across different time periods.

Growth Metrics

Growth metrics for Abbott Laboratories (ABT) and DaVita (DVA)
Metric	ABT	DVA
Revenue Growth (YoY)	5.67%	6.46%
Revenue Growth (3Y CAGR)	0.51%	5.53%
EPS Growth (YoY)	-51.31%	-8.29%
EPS Growth (3Y CAGR)	-1.65%	18.93%

Financial Strength

Current Ratio (MRQ)

Both Abbott Laboratories (ABT) at 1.46 and DaVita (DVA) at 1.41 carry current ratio within their industries’ typical mid-ranges, suggesting balanced short-term liquidity relative to peers.

ABT

Health Care Equipment & Services industry group

1.46

Max: 7.59
Q3: 4.00
Median: 1.98
ABT: 1.46
Q1: 1.37
Min: 0.30

DVA

Health Care Equipment & Services industry group

1.41

Max: 7.59
Q3: 4.00
Median: 1.98
DVA: 1.41
Q1: 1.37
Min: 0.30

Abbott Laboratories (ABT) vs. DaVita (DVA): A comparison of their current ratio against the Health Care Equipment & Services industry group benchmark.

Debt / Equity (MRQ)

Abbott Laboratories (ABT) at 0.61 is near its industry mid-range for debt-to-equity ratio, while DaVita (DVA) at 11.90 sits above its benchmark range, pointing to a heavier debt load relative to equity.

ABT

Health Care Equipment & Services industry group

0.61

Max: 1.88
Q3: 0.91
ABT: 0.61
Median: 0.58
Q1: 0.16
Min: 0.00

DVA

Health Care Equipment & Services industry group

11.90

DVA: 11.90
Max: 1.88
Q3: 0.91
Median: 0.58
Q1: 0.16
Min: 0.00

Abbott Laboratories (ABT) vs. DaVita (DVA): A comparison of their debt-to-equity ratio against the Health Care Equipment & Services industry group benchmark.

Financial Strength Metrics

Financial strength metrics for Abbott Laboratories (ABT) and DaVita (DVA)
Metric	ABT	DVA
Current Ratio (MRQ)	1.46	1.41
Debt / Equity (MRQ)	0.61	11.90
Net Debt / EBITDA	2.37	4.51

Dividends

Dividend Yield (TTM)

DaVita (DVA) pays no dividend (yield 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile Abbott Laboratories (ABT) reports a yield of 2.22%, ranking against industry peers normally.

ABT

Health Care Equipment & Services industry group

2.22%

ABT: 2.22%
Max: 0.00%
Q3: 0.00%
Median: 0.00%
Q1: 0.00%
Min: 0.00%

DVA

Health Care Equipment & Services industry group

0.00%

DVA: 0.00%
Max: 0.00%
Q3: 0.00%
Median: 0.00%
Q1: 0.00%
Min: 0.00%

Abbott Laboratories (ABT) vs. DaVita (DVA): A comparison of their dividend yield against the Health Care Equipment & Services industry group benchmark.

Dividend Payout Ratio (TTM)

DaVita (DVA) pays no dividend (payout 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile Abbott Laboratories (ABT) reports a payout of 92.54%, ranking against industry peers normally.

ABT

Health Care Equipment & Services industry group

92.54%

ABT: 92.54%
Max: 0.00%
Q3: 0.00%
Median: 0.00%
Q1: 0.00%
Min: 0.00%

DVA

Health Care Equipment & Services industry group

0.00%

DVA: 0.00%
Max: 0.00%
Q3: 0.00%
Median: 0.00%
Q1: 0.00%
Min: 0.00%

Abbott Laboratories (ABT) vs. DaVita (DVA): A comparison of their payout ratio against the Health Care Equipment & Services industry group benchmark.

Dividend Metrics

Dividend metrics for Abbott Laboratories (ABT) and DaVita (DVA)
Metric	ABT	DVA
Dividend Yield (TTM)	2.22%	0.00%
Dividend Payout Ratio (TTM)	92.54%	0.00%

Valuation

P/E Ratio (TTM)

DaVita (DVA) at 14.49 sits in the cheaper P/E ratio quartile, while Abbott Laboratories (ABT) at 41.02 is closer to its industry’s usual earnings multiple — a discount for DVA, though growth and earnings durability still matter.

ABT

Health Care Equipment & Services industry group

41.02

Max: 80.41
Q3: 47.62
ABT: 41.02
Median: 29.93
Q1: 21.19
Min: 4.21

DVA

Health Care Equipment & Services industry group

14.49

Max: 80.41
Q3: 47.62
Median: 29.93
Q1: 21.19
DVA: 14.49
Min: 4.21

Abbott Laboratories (ABT) vs. DaVita (DVA): A comparison of their P/E ratio against the Health Care Equipment & Services industry group benchmark.

P/S Ratio (TTM)

DaVita (DVA) at 0.85 sits in the cheaper P/S ratio quartile while Abbott Laboratories (ABT) at 3.95 prices around its industry’s middle — DVA costs less per dollar of sales, though read it alongside growth and margins.

ABT

Health Care Equipment & Services industry group

3.95

Max: 8.80
Q3: 4.32
ABT: 3.95
Median: 2.13
Q1: 1.10
Min: 0.03

DVA

Health Care Equipment & Services industry group

0.85

Max: 8.80
Q3: 4.32
Median: 2.13
Q1: 1.10
DVA: 0.85
Min: 0.03

Abbott Laboratories (ABT) vs. DaVita (DVA): A comparison of their P/S ratio against the Health Care Equipment & Services industry group benchmark.

P/B Ratio (MRQ)

DaVita (DVA) reports a negative P/B ratio of -20.52, meaning negative book equity — the multiple itself is not meaningful for valuation. Meanwhile Abbott Laboratories (ABT) reports 3.73, ranking against industry peers normally.

ABT

Health Care Equipment & Services industry group

3.73

Max: 11.68
Q3: 6.12
ABT: 3.73
Median: 3.00
Q1: 1.73
Min: -1.31

DVA

Health Care Equipment & Services industry group

-20.52

Max: 11.68
Q3: 6.12
Median: 3.00
Q1: 1.73
Min: -1.31
DVA: -20.52

Abbott Laboratories (ABT) vs. DaVita (DVA): A comparison of their P/B ratio against the Health Care Equipment & Services industry group benchmark.

Valuation Metrics

Valuation metrics for Abbott Laboratories (ABT) and DaVita (DVA)
Metric	ABT	DVA
P/E Ratio (TTM)	41.02	14.49
P/S Ratio (TTM)	3.95	0.85
P/B Ratio (MRQ)	3.73	-20.52
Free Cash Flow Yield (TTM)	3.19%	7.52%